Sanofi India Ltd.

Financial

	Sanofi India	Jubilant Pharmova	Natco Pharma
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	0.6 %	n/a	31.2 %
Unclassified
R&D as a % of Total Sales	0.0	0.33 %	7.6 %
Financials
5 yr Average ROE	52.02 %	8.35 %	13.06 %
5yr average Equity Multiplier	4.62	2.0	1.18
5yr Average Asset Turnover Ratio	0.47	0.59	0.46
5yr Avg Net Profit Margin	24.38 %	7.13 %	23.09 %
Price to Book	17.58	2.56	2.26
P/E	36.61	24.2	8.68
5yr Avg Cash Conversion Cycle	4.83 Days	-19.21 Days	10.54 Days
Inventory Days	66.8 Days	81.78 Days	99.95 Days
Days Receivable	31.98 Days	51.11 Days	86.16 Days
Days Payable	63.37 Days	173.51 Days	154.15 Days
5yr Average Interest Coverage Ratio	906.11	3.98	46.61
5yr Avg ROCE	27.19 %	9.05 %	16.05 %
5yr Avg Operating Profit Margin	24.71 %	18.69 %	30.17 %
5 yr average Debt to Equity	0.0	0.64	0.06
5yr CAGR Net Profit	31.63 %	-38.8 %	24.68 %
5yr Average Return on Assets	11.5 %	4.23 %	11.07 %
Shareholdings
Promoter Holding	60.4 %	50.68 %	49.56 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.75 %
Change in Mutual Fund Holding (3 Yrs)	1.07 %	3.61 %	-5.54 %

Business

	Sanofi India	Jubilant Pharmova	Natco Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up India branded pharmaceuticals 0.72 Anti-allergic 10.21 Crop Health 0 Radiopharmaceuticals 44.9 Life science chemicals 0 Contract Research and Development Services 6.7 Contract Manufacturing 16.81 Specialty intermediates 0 Solid dosage formulations 10.82 Pharmaceutical 0 API(Domestic & Exports) 0 Formulation 0 Nutritional products 0 Active Pharmaceutical Ingredient (API) 9.26 Others 0.58	Product Wise Break-Up India Branded pharmaceuticals 0 Allergy therapy products 0 Crop Protection 2.0 Radiopharmaceuticals 0 Life science chemicals 0 0 0 Specialty intermediates 0 Solid dosage formulations 0 Pharmaceutical 0 Active Pharmaceutical Ingredient (API) 10.0 Formulations 59.0 Nutritional products 0 Active pharmaceutical ingredients 0 Others 29.0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 38.81 Cardiac Science 17.42 Respiratory Systems 13.48 Gastro Intestinal 10.56 Pain Management 7.15 Central Nervous System (CNS) 6.86 Anti-Infective 5.72 DERMA 0 VMN 0 Oncology 0	-	Therapeutic Area Wise Break-Up - Domestic Gastro Intestinal 0 Central Nervous System (CNS) 0 DERMA 0 Anti - Diabetes 0 Cardiac Science 0 Anti-Infective 0 Pain Management 0 VMN 0 Oncology 58.79 Respiratory Systems 0 Others 41.21
Location Wise Break-Up	Location Wise Break-Up India 81.47 Singapore 17.88 Rest of the World 0 China 0 Americas and Europe 0 USA 0 Others 0.65	Location Wise Break-Up Singapore 0 Rest of the World 7.5 Americas and Europe 90.17 China 0 India 2.33 USA 0	Location Wise Break-Up Singapore 0 Rest of the World 15.24 Americas and Europe 0 China 0 India 14.27 USA 70.49

Sanofi India Ltd.

SIGN UP FOR FREE